CLINICAL_TRIALS
trial_result
· 2022-02-08
Clinical Trial Update: Fenofibrate in Type 2 Diabetes [Phase 4]
Summary
A Phase 4 trial of fenofibrate in type 2 diabetes has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Diabetes Mellitus, Type II | Phase 4 | Status: COMPLETED | Results posted: 2022-02-08